SUBSCRIBERS

Eli Lilly unit opens research facility, inks MOU to work on trials

Ng Ren Jye

Published Wed, Nov 7, 2018 · 09:50 PM

    Singapore

    LILLY Centre for Clinical Pharmacology (LCCP), a subsidiary of US-based Eli Lilly and Company, has opened a 40,600 square foot, S$30 million research facility in Biopolis.

    LCCP conducts clinical trials in healthy participants and patients, with a primary focus on first human dose studies and the development of new medicines for diabetes.